MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway. Hassan G, Afify SM, Du J, Nawara HM, et al. Biochem Biophys Res Commun 2021;583:49-55.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hassan G, Afify SM, Du J, Nawara HM, et al. MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway. Biochem Biophys Res Commun 2021;583:49-55.
PMID: 34735879